欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
SE/H/2034/001
药品名称
Bilastin Teva
活性成分
bilastine 20.0 mg
剂型
Tablet
上市许可持有人
Teva B.V., Netherlands
参考成员国 - 产品名称
Sweden (SE)
互认成员国 - 产品名称
France (FR)
Spain (ES)
Czechia (CZ)
Bilastin Teva
Portugal (PT)
Poland (PL)
Hungary (HU)
Bilastine Teva 20 mg tabletta
Bulgaria (BG)
Bilastine Tiefenbacher
许可日期
2021/03/18
最近更新日期
2024/09/19
药物ATC编码
R06AX29 bilastine
申请类型
TypeLevel1:
Known Active Substance
TypeLevel2:
Initial Application
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final PL
|
SE_H_2034_001_Final PL
Date of last change:2024/09/06
Final SPC
|
SE_H_2034_001_Final SPC
Date of last change:2024/09/06
PubAR
|
SE_H_2034_001_PAR
Date of last change:2024/09/06
PubAR Summary
|
SE_H_2034_001_PAR Summary
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase